In a person who ingested 125 mg oxycodone (chewed 25 tablets of 5 mg) and 60 mg clonazepam (60 × 1 mg tablets), will they lose consciousness from the oxycodone before the clonazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Life-Threatening Emergency: Both Drugs Will Cause Simultaneous CNS and Respiratory Depression

This patient will not "pass out first" from one drug versus the other—both oxycodone and clonazepam will act synergistically and simultaneously to cause profound CNS depression, respiratory failure, and likely death. The doses ingested (125 mg oxycodone and 60 mg clonazepam) are massively supratherapeutic and represent a critical polysubstance overdose with extremely high mortality risk.

Why This Question Has No Meaningful Answer

The premise of the question—whether oxycodone or clonazepam causes loss of consciousness "first"—is clinically irrelevant because:

  • Synergistic toxicity dominates: Opioids and benzodiazepines potentiate each other's CNS and respiratory depressant effects through different mechanisms (opioid receptors vs. GABA-A receptors), creating a combined effect far worse than either alone 1
  • Both drugs are rapidly absorbed: When chewed, immediate-release formulations reach peak plasma concentrations within 30-60 minutes, meaning both drugs will exert maximal effects nearly simultaneously
  • The lethal mechanism is the same: Both cause respiratory depression leading to hypoxemia, hypercarbia, aspiration, and cardiopulmonary arrest 1, 2, 3

The Actual Clinical Reality

Dose Context

  • Oxycodone 125 mg: Typical therapeutic doses are 5-15 mg every 4-6 hours. This represents 8-25 times a single therapeutic dose 2
  • Clonazepam 60 mg: Typical therapeutic doses are 0.5-2 mg daily. This represents 30-120 times the daily therapeutic dose 3

Expected Clinical Course

Within 15-30 minutes:

  • Onset of sedation, confusion, slurred speech
  • Progressive respiratory depression begins
  • Miosis (pinpoint pupils from oxycodone)
  • Hypotension and bradycardia

Within 30-90 minutes:

  • Profound unresponsiveness/coma
  • Severe respiratory depression or apnea
  • Aspiration risk (vomiting is common with opioid overdose) 2
  • Hypoxemia leading to cyanosis, seizures, cardiac arrest

Documented fatal outcome: A case report of combined oxycodone-clonazepam overdose showed plasma concentrations of 0.60 μg/mL oxycodone and 1.41 μg/mL clonazepam resulted in death from severe CNS/respiratory depression, collapsed lungs, aspirated mucus, and heart failure 4. The doses in your scenario are substantially higher.

Critical Management Priorities

Immediate Actions (if patient presents alive)

  1. Airway protection is paramount: Anticipate need for endotracheal intubation given the massive doses and aspiration risk 1

  2. Naloxone administration: Give naloxone 0.4-2 mg IV/IM/intranasal immediately, repeat every 2-3 minutes as needed 1. Naloxone should be given FIRST before considering flumazenil in combined overdoses 1

    • Titrate to restore respiratory drive and protective airway reflexes, NOT full consciousness
    • Prepare for continuous infusion (two-thirds of waking dose per hour) given oxycodone's longer duration of action
  3. DO NOT give flumazenil: Despite the massive benzodiazepine dose, flumazenil is contraindicated in this polysubstance overdose 1

    • Risk of precipitating seizures
    • Risk of unmasking opioid toxicity
    • Does not reverse respiratory depression in mixed overdoses
    • Has no role in cardiac arrest 1
  4. Supportive care:

    • Bag-mask ventilation or mechanical ventilation as needed
    • IV access, cardiac monitoring
    • Activated charcoal is likely too late if tablets were chewed 30+ minutes ago
    • Contact Poison Control (1-800-222-1222) immediately 1

Common Pitfalls

  • Assuming one drug will dominate: The synergistic effect means 1+1=5, not 2
  • Giving flumazenil: This can precipitate life-threatening complications in mixed overdoses 1
  • Inadequate naloxone dosing: May need repeated doses or continuous infusion
  • Premature extubation: Benzodiazepines have much longer half-lives than naloxone; patients can re-sedate

Prognostic Reality

This ingestion carries extremely high mortality risk. Death is most often associated with polysubstance use, especially benzodiazepines with opioids 3. The pathophysiology includes:

  • Respiratory arrest from combined CNS depression
  • Aspiration pneumonitis
  • Hypoxic brain injury
  • Cardiovascular collapse 2, 4

Survival depends entirely on immediate access to advanced life support, aggressive airway management, and high-dose naloxone therapy.

Related Questions

What are the drug interactions and safety concerns of combining mirtazapine 15 mg with OxyContin (extended‑release oxycodone)?
In an otherwise healthy adult with a pacemaker who ingested 125 mg of oxycodone and 60 mg of clonazepam, how long will death occur without medical intervention?
Will a patient with a pacemaker who ingests 125 mg oxycodone and 60 mg clonazepam lose consciousness before any cardiac complications occur?
Can ingesting 25 tablets of 5 mg oxycodone and 60 tablets of 1 mg clonazepam simultaneously, after chewing them, be fatal?
In a patient with a massive oxycodone (125 mg) and clonazepam (60 mg) overdose who has a pacemaker, does the pacemaker change the need for immediate airway protection and aggressive respiratory support?
What is the appropriate dosing schedule for risperidone 2–3 mg by mouth and lorazepam 1–2 mg by mouth?
What is the recommended treatment for focal seizures?
What is the medial vestibulospinal tract?
What is a concise quick‑reference guide for psychiatric medications, including starting and maintenance doses, evidence‑based guidelines for initiating long‑acting injectable antipsychotics, and safety monitoring parameters, for adults receiving medication‑assisted treatment in an opioid treatment program?
In a patient with a massive oxycodone (125 mg) and clonazepam (60 mg) overdose who has a pacemaker, does the pacemaker change the need for immediate airway protection and aggressive respiratory support?
Within how many days do acute-phase reaction symptoms typically appear after a zoledronic acid infusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.